BRIEF-Neurocrine Biosciences prices $450 mln convertible senior notes offering
April 26, 2017 at 19:02 PM EDT
* Priced offering of $450.0 million aggregate principal amount of 2.25% convertible senior notes due 2024 Source text for Eikon: Further company coverage: